record #41189970837146 | qmc | 86217530 | | 664166 | 8/22/1997 12:00:00 am | unstable angina | signed | dis | admission date: 8/5/1997 report status: signeddischarge date: 2/27/1997principal diagnosis: coronary artery disease.operative procedures: coronary artery bypass graft x3 , 5/16/97 . history of present illness: mrs. hannen is a 72-year-old femalewith no coronary artery disease whowas transferred from an outside hospital with unstable angina , tothe cardiology service. her risk factors include positive familyhistory , hypertension , and hypercholesterolemia. her cardiachistory included a myocardial infarction in 1983 , followed bypost-infarct sustained in 1989 , which was treated medically. shehad a preop evaluation prior to bladder surgery , at which time , anett was positive and cardiac cath revealed 70% proximal lad , 70%mid lad , 70% distal lad , 50% proximal circumflex , total occlusionof obtuse marginal i , an 80% occlusion obtuse marginal iiocclusion. she was managed medically without any further symptomsuntil 1/10 when she developed chest pain on exertion , which wasagain treated medically. on 8/10/97 , she was admitted to ton valley hospital and medical center for elective bladder suspension which was attemptedlaparoscopically but complicated by bladder rupture and wasconverted to an open procedure. intraoperatively , she was noted tohave st changes. she was taken to the icu where she ruled out fora myocardial infarction. however , subsequently , she developedchest pain and shortness of breath , with st depression. she wastherefore transferred to the nin vensca memorial for cardiaccatheterization and possible coronary revascularization.past medical history: hypertension , hypercholesterolemia , coronaryartery disease.past surgical history: bladder suspension in 1995 and 1997.allergies: no known drug allergies.medications: procardia xl 30 mg p.o. q.d.; atenolol 30 mg p.o.q.d.; mevacor 20 mg p.o. q.d.; premarin 0.625 mg p.o.q.d.; bactrim ds 1 tab p.o. b.i.d.; dilatrate 40 mg t.i.d.;compazine 10 mg p.r.n. q.8h.; darvocet 100 mg p.r.n. q.4h.; heparinsubcu.social history: the patient does not smoke.family history: significant for coronary artery disease.physical examination: vital signs - afebrile , pulse 77 , regular , bp120/60 , two liters saturating 97%. skin - no jaundice , no anemia.no clubbing , cyanosis , or pedal edema. neck - soft right carotidbruit. lungs - clear to auscultation. heart - normal heartsounds , ii/vi systolic murmur at left sternal border. abdomen -soft , non-tender , non-distended. surgical incision healing well.extremities - no varicose veins , bilateral dorsalis pedis , 2+edema.laboratory data: na 133 , k 3.1 , cl 100 , co2 30 , bun 4 , creatinine0.6 , glucose 106. white count 10.9 , hematocrit27.4 , platelets 211. ekg normal sinus rhythm , with q-waves in avf.chest x-ray shows no active infiltrate.hospital course: she was taken to the cath lab and underwent acardiac catheterization on 0/14/97 .  thisrevealed an occluded right coronary artery , 70% left circumflexstenosis , a totally occlused obtuse marginal , 70-80% lad stenosis ,serial 70% stenosis in diagonal i , left ventricular ejectionfraction of 50% , and inferior akinesis.she was taken to the operating room on 2/24/97 and underwentcoronary artery bypass graft x3 , lima to lad , saphenous vein graftto posterior descending artery , saphenous vein graft to obtusemarginal.postoperatively , he remained in the icu for three days postopbecause of rapid atrial fibrillation which required increasingamounts of beta blocker therapy. she was transferred out of theunit on postop day #4. she underwent a cystogram on 5/0/97 whichdid not show any evidence of a leak. she continued to remain inatrial fibrillation intermittently , which responded to increasingdose of lopressor and lateral conversion of lopressor to atenolol100 mg b.i.d. she continued to develop atrial fibrillation everymorning in spite of increasing doses of atenolol. therefore ,procainamide was started on 1/30/97 and she is being discharged on5/2/97 after having remained in sinus rhythm for 24 hours onatenolol 100 mg b.i.d. and procan sr 500 mg q.i.d.discharge medications: atenolol 100 mg p.o. b.i.d.; percocet 1-2tabs p.o. q.4h. p.r.n. pain; coumadin doseto be based on inr range of 2-2.5; axid 150 mg p.o. b.i.d.;cephradine 500 mg q.i.d. x7 days for redness at saphenous veingraft harvest site above the medial malleolus; procan sr 750 mgp.o. q.i.d.discharge diet: no diet restrictions.discharge activity: as tolerated.discharge follow-up: arrangements have been made for follow-upwith dr. friedeck and cardiology in one week ,and dr. barcus in 4-6 weeks.discharge disposition: to home , with services.condition on discharge: stable condition.dictated by: diego plake , m.d. qw54attending: stanton e. varano , m.d. jz8  xc290/2291batch: 70154 index no. hoage86om1 d: 5/2/97t: 0/14/97[report_end]